Condition: Colorectal Cancer · Sponsor: EMD Serono Research & Development Institute, Inc.
The purpose of this first in-human study is to evaluate the safety, tolerability, pharmacokinetics, and preliminary clinical activity of M9140 in advanced solid tumors. This study contains 2 parts: Dose escalation (Part 1) and dose expansion (Part 2) Study details include: * Study Duration per participant: Approximately 4 months for Part 1 and 8 months for Part 2 * M9140 is not available through an expanded access program
This description comes directly from the study's public registry record.
US Medical Information · 888-275-7376 · eMediUSA@emdserono.com
Communication Center · +49 6151 72 5200 · service@emdgroup.com
Always discuss trial participation with your own doctor first.
| California Cancer Associates for Research & Excellence, Inc. | Encinitas, California, United States | Completed |
| California Cancer Associates for Research & Excellence, Inc. | Fresno, California, United States | Completed |
| Rhode Island Hospital | Providence, Rhode Island, United States | Recruiting |
| Mary Crowley Cancer Research | Dallas, Texas, United States | Recruiting |
| MD Anderson Cancer Center - Oncology | Houston, Texas, United States | Recruiting |
| NEXT Oncology | San Antonio, Texas, United States | Recruiting |
| The Ottawa Hospital Cancer Centre | Ottawa, Canada | Recruiting |
| University Health Network - Princess Margaret Cancer Centre | Toronto, Canada | Recruiting |
| National Cancer Center Hospital - Dept of Gastroenterology | Chūōku, Japan | Recruiting |
| National Cancer Center Hospital East | Kashiwa-shi, Japan | Recruiting |
| Saitama Cancer Center | Kitaadachi-gun, Japan | Recruiting |
| Cancer Institute Hospital of JFCR | Kōtoku, Japan | Recruiting |
+ 23 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05464030